Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid

Alzheimer's and Dementia

Volumn 8, Issue 4, 2012, Pages 304-311

  Alexopoulos, Panagiotis ^a   Tsolakidou, Amalia ^a   Roselli, Francesco ^b   Arnold, Anila ^a   Grimmer, Timo ^a   Westerteicher, Christine ^a   Leante, Maria Rosaria ^b   Förstl, Hans ^a   Livrea, Paolo ^b   Kurz, Alexander ^a   Perneczky, Robert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

AD; CSF; MCI; sAPP ; sAPP

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; SOLUBLE AMYLOID PRECURSOR PROTEIN ALPHA; SOLUBLE AMYLOID PRECURSOR PROTEIN BETA; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROBIOLOGY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SEX DIFFERENCE;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; APOLIPOPROTEINS E; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS;

EID: 84863207476     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.04.009     Document Type: Article

References (47)

1. L. Minati, T. Edginton, M.G. Bruzzone, and G. Giaccone Current concepts in Alzheimer's disease: a multidisciplinary review Am J Alzheimers Dis Other Demen 24 2009 95 121
2. D.P. Chapman, S.M. Williams, T.W. Strine, R.F. Anda, and M.J. Moore Dementia and its implications for public health Prev Chronic Dis 3 2006 A34
3. H. Braak, and E. Braak Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections Brain Pathol 1 1991 213 216
4. G. Thinakaran, and E.H. Koo Amyloid precursor protein trafficking, processing, and function J Biol Chem 283 2008 29615 29619
5. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
6. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, and P. Denis Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741
7. V.W. Chow, M.P. Mattson, P.C. Wong, and M. Gleichmann An overview of app processing enzymes and products Neuromolecular Med 12 2010 1 12
8. J.H. Stockley, and C. O'Neill Understanding BACE1: essential protease for amyloid-beta production in Alzheimer's disease Cell Mol Life Sci 65 2008 3265 3289
9. R. Postina, A. Schroeder, I. Dewachter, J. Bohl, U. Schmitt, and E. Kojro A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model J Clin Invest 113 2004 1456 1464 (Pubitemid 39071701)
10. D.M. Skovronsky, D.B. Moore, M.E. Milla, R.W. Doms, and V.M. Lee Protein kinase c-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network J Biol Chem 275 2000 2568 2575 (Pubitemid 30082022)
11. A.D. Randall, J. Witton, C. Booth, A. Hynes-Allen, and J.T. Brown The functional neurophysiology of the amyloid precursor protein (app) processing pathway Neuropharmacology 59 2010 243 267
12. R.W. Shin, T.C. Saido, M. Maeda, and T. Kitamoto Novel alpha-secretase cleavage of Alzheimer's amyloid beta precursor protein in the endoplasmic reticulum of cos7 cells Neurosci Lett 376 2005 14 19 (Pubitemid 40202929)
13. S. Sankaranarayanan, E.A. Price, G. Wu, M.C. Crouthamel, X.P. Shi, and K. Tugusheva In vivo beta-secretase 1 inhibition leads to brain abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1 J Pharmacol Exp Ther 324 2008 957 969 (Pubitemid 351397853)
14. K.D. Coon, A.J. Myers, D.W. Craig, J.A. Webster, J.V. Pearson, and D.H. Lince A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease J Clin Psychiatry 68 2007 613 618 (Pubitemid 46663046)
15. A. Drzezga, T. Grimmer, G. Henriksen, M. Muhlau, R. Perneczky, and I. Miederer Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease Neurology 72 2009 1487 1494
16. T. Grimmer, S. Tholen, B.H. Yousefi, P. Alexopoulos, A. Forschler, and H. Forstl Progression of cerebral amyloid load is associated with the apolipoprotein e epsilon4 genotype in Alzheimer's disease Biol Psychiatry 68 2010 879 884
17. E.M. Reiman, K. Chen, X. Liu, D. Bandy, M. Yu, and W. Lee Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease Proc Natl Acad Sci U S A 106 2009 6820 6825
18. P. Seubert, C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, and D. Davis Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids Nature 359 1992 325 327
19. P. Lewczuk, H. Kamrowski-Kruck, O. Peters, I. Heuser, F. Jessen, and J. Popp Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study Mol Psychiatry 15 2010 138 145
20. B. Thalmann, and A.U. Monsch The consortium to establish a registry for Alzheimer's disease. Neuropsychologische Testbatterie 1997 Memory Clinic Basel Basel, Switzerland
21. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
22. Dilling H, Mombour W, Schmidt MH, Schulte-Markowrt E, eds. Weltgesundheitsorganisation: internationale klassifikation psychischer störungen, icd-10 kapitel v (f) forschungskriterien. Bern: Huber, 1994.
23. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease Neurology 34 1984 939 944 (Pubitemid 14076461)
24. B. Winblad, K. Palmer, M. Kivipelto, V. Jelic, L. Fratiglioni, and L.O. Wahlund Mild cognitive impairment-beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment J Intern Med 256 2004 240 246 (Pubitemid 39222993)
25. A. Zivelin, N. Rosenberg, H. Peretz, Y. Amit, N. Kornbrot, and U. Seligsohn Improved method for genotyping apolipoprotein e polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes Clin Chem 43 1997 1657 1659
26. N. Mattsson, M. Axelsson, S. Haghighi, C. Malmestrom, G. Wu, and R. Anckarsater Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis Mult Scler 15 2009 448 454
27. P. Selnes, K. Blennow, H. Zetterberg, R. Grambaite, L. Rosengren, L. Johnsen, V. Stenset, and T. Fladby Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid Cerebrospinal Fluid Res 7 2010 10
28. N. Mattsson, D. Bremell, R. Anckarsater, K. Blennow, H. Anckarsater, H. Zetterberg, and L. Hagberg Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism BMC Neurol 10 2010 51
29. A. Gabelle, S. Roche, C. Geny, K. Bennys, P. Labauge, and Y. Tholance Correlations between soluble alpha/beta forms of amyloid precursor protein and abeta38, 40, and 42 in human cerebrospinal fluid Brain Res 1357 2010 175 183
30. H. Zetterberg, U. Andreasson, O. Hansson, G. Wu, S. Sankaranarayanan, and M.E. Andersson Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease Arch Neurol 65 2008 1102 1107
31. P. Alexopoulos, A. Kurz, P. Lewczuk, J. Kornhuber, J. Wiltfang, W. Maier, H. Forstl, and R. Perneczky The sortilin-related receptor sorl1 and the amyloid cascade: a possible explanation for the concurrent elevation of CSF soluble APPalpha and APPbeta in Alzheimer's disease Int J Geriatr Psychiatry 25 2010 542 543
32. M. Rohe, A.S. Carlo, H. Breyhan, A. Sporbert, D. Militz, and V. Schmidt Sortilin-related receptor with a-type repeats (sorla) affects the amyloid precursor protein-dependent stimulation of ERK signaling and adult neurogenesis J Biol Chem 283 2008 14826 14834
33. T.E. Willnow, C.M. Petersen, and A. Nykjaer Vps10p-domain receptors - regulators of neuronal viability and function Nat Rev Neurosci 9 2008 899 909
34. Y. Zhao, J.G. Cui, and W.J. Lukiw Reduction of sortilin-1 in Alzheimer hippocampus and in cytokine-stressed human brain cells Neuroreport 18 2007 1187 1191 (Pubitemid 46988077)
35. S. Lehericy, M. Marjanska, L. Mesrob, M. Sarazin, and S. Kinkingnehun Magnetic resonance imaging of Alzheimer's disease Eur Radiol 17 2007 347 362 (Pubitemid 46150544)
36. K. Sennvik, J. Fastbom, M. Blomberg, L.O. Wahlund, B. Winblad, and E. Benedikz Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients Neurosci Lett 278 2000 169 172 (Pubitemid 30009484)
37. Z. Zhong, M. Ewers, S. Teipel, K. Burger, A. Wallin, and K. Blennow Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment Arch Gen Psychiatry 64 2007 718 726 (Pubitemid 46878672)
38. M. Ewers, Z. Zhong, K. Burger, A. Wallin, K. Blennow, S.J. Teipel, Y. Shen, and H. Hampel Increased CSF-BACE 1 activity is associated with APOE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease Brain 131 2008 1252 1258
39. A. Olsson, K. Hoglund, M. Sjogren, N. Andreasen, L. Minthon, and L. Lannfelt Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients Exp Neurol 183 2003 74 80 (Pubitemid 37075858)
40. F. Chowdhury, A. Williams, and P. Johnson Validation and comparison of two multiplex technologies, Luminex and mesoscale discovery, for human cytokine profiling J Immunol Methods 340 2009 55 64
41. P. Lewczuk, H. Kamrowski-Kruck, O. Peters, I. Heuser, F. Jessen, and J. Popp Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study Mol Psychiatry 15 2010 138 145
42. F. Hulstaert, K. Blennow, A. Ivanoiu, H.C. Schoonderwaldt, M. Riemenschneider, and P.P. De Deyn Improved discrimination of ad patients using beta-amyloid(1-42) and tau levels in CSF Neurology 52 1999 1555 1562 (Pubitemid 29220627)
43. H. Hampel, and K. Broich Enrichment of MCI and early Alzheimer's disease treatment trials using neurochemical and imaging candidate biomarkers J Nutr Health Aging 13 2009 373 375
44. M. Vandermeeren, M. Mercken, E. Vanmechelen, J. Six, A. van de Voorde, J.J. Martin, and P. Cras Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay J Neurochem 61 1993 1828 1834 (Pubitemid 23317209)
45. L. Placanica, L. Zhu, and Y.M. Li Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease PLoS ONE 4 2009 e5088
46. R. Brookmeyer, S. Gray, and C. Kawas Projections of Alzheimer's disease in the united states and the public health impact of delaying disease onset Am J Public Health 88 1998 1337 1342 (Pubitemid 28402270)
47. L.X. Hy, and D.M. Keller Prevalence of ad among whites: a summary by levels of severity Neurology 55 2000 198 204 (Pubitemid 30604618)